NFKB1 and inflammatory bowel disease: Nuclear factor‐kappaB (NF‐κB), a pivotal transcriptional regulator of pro‐inflammatory cascades, exhibits sustained activation in chronic immune disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), driving pathological progression (Mukherjee et al. 2024).